Emergent Biosolutions Inc. (EBS) vs Ironwood Pharmaceuticals, Inc. (IRWD)
- Emergent Biosolutions Inc. EBS 6.38 −11.14%
- Ironwood Pharmaceuticals, Inc. IRWD 3.50 −7.16%
Emergent Biosolutions Inc. and Ironwood Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Ironwood Pharmaceuticals, Inc. is the larger, with a market value of $623.0M against $368.1M — 1.7× the size. Emergent Biosolutions Inc. has negative trailing earnings, so its P/E is not meaningful; Ironwood Pharmaceuticals, Inc. trades at 4.4×. Ironwood Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 26.2% against −9.56%. Ironwood Pharmaceuticals, Inc. has the higher net margin (33.4% vs −23.0%) and the higher return on invested capital (101.6% vs −5.27%). Across the 20 metrics below, Ironwood Pharmaceuticals, Inc. leads on 16 and Emergent Biosolutions Inc. on 4.
Valuation
Profitability
| Metric | EBS | IRWD | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 55.87% | 100.00% | 53.94% |
| Operating margin | (8.57%) | 60.15% | 0.00% |
| Net margin | (22.96%) | 33.36% | 0.00% |
| Free cash flow margin | 11.18% | 47.66% | 0.00% |
| Return on equity | (40.29%) | (55.26%) | (0.40%) |
| Return on assets | (13.95%) | 41.35% | (3.32%) |
| Return on invested capital | (5.27%) | 101.61% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack